Delivery Order SPE2DE24DA017-SPE2D625F0XWY
- Not listed
- Arthrex Inc., a leading orthopedic medical device manufacturer headquartered in Naples, Florida, was awarded a delivery order valued at $1,320.00 for an Allograft OATS (Osteochondral Autograft Transfer System) disposable kit in 18mm size. This fixed-price delivery order, issued on August 11, 2025, with an ultimate completion date of August 14, 2025, was awarded by the Defense Logistics Agency's Medical Supply Chain without any set-aside designation. The place of performance is located in Naples,...
- Arthrex Inc., a leading orthopedic medical device manufacturer headquartered in Naples, Florida, has been awarded a delivery order valued at $1,760.22 for an Allograft OATS (Osteochondral Autograft Transfer System) disposable kit in 20mm size. The contract, awarded on August 15, 2025, with an ultimate completion date of August 20, 2025, is a fixed-price delivery order with economic price adjustment provisions. This award is not set aside for any specific business type and represents a...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order on April 22, 2025, for an Allograft OATS (Osteochondral Autograft Transfer System) Disposable Kit in 22.5mm size, valued at $1,320.00. This fixed-price contract with economic price adjustment provisions is effective through April 28, 2025, and will be fulfilled at the company's Naples, Florida facility. The award was made through the Defense Logistics Agency's...
- Arthrex Inc., a leading minimally invasive orthopedic medical device manufacturer headquartered in Naples, Florida, was awarded a delivery order valued at $9,429.61 on August 21, 2025, for OATS (Osteochondral Autograft Transfer System) kits designed for 16mm allograft plugs. The order, issued under fixed-price terms with economic price adjustment provisions, is scheduled for completion by August 26, 2025, and will be performed in Naples, Florida. This delivery order was issued without a...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a delivery order valued at $1,320.00 from the Defense Logistics Agency's Medical Supply Chain on August 18, 2025, for an Allograft OATS (Osteochondral Autograft Transfer System) Disposable Kit in 25mm configuration. This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by September 2, 2025, and represents a task order under Arthrex's...
- Arthrex Inc., a leading orthopedic medical device manufacturer based in Naples, Florida, received a delivery order award valued at $1,320.00 for a Patella Oats Disposable Kit (Medium) from the Defense Logistics Agency's Medical Supply Chain on July 29, 2025. The delivery order, issued under fixed-price terms with economic price adjustment provisions, is scheduled for completion by August 1, 2025, and will be fulfilled at the company's Naples, FL facility. This award carries no set-aside...
- On June 30, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,320.00 to Arthrex Inc. for an Allograft OATS (Osteochondral Autograft Transfer System) Disposable Kit, 15mm. This fixed-price delivery order with economic price adjustment capability is scheduled for completion by July 3, 2025, with performance to be executed in Naples, Florida. The award represents a continuation of Arthrex's role as a key supplier of orthopedic medical technologies to...
- The U.S. Department of Defense, through its Medical Supply Chain division of the Defense Logistics Agency (DLA), awarded a delivery order to Arthrex Inc. for an Allograft OATS (Osteochondral Autograft Transfer System) Disposable Kit in 20mm configuration. This fixed-price delivery order, valued at $4,890.60 with economic price adjustment provisions, was awarded on August 20, 2025, with an ultimate completion date of August 25, 2025. The order carries no set-aside designation, reflecting...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a $19,197.42 fixed-price delivery order with economic price adjustment on August 1, 2025, for the implementation of an AutoGraft GraftLink CP 2 system. This delivery order, with an ultimate completion date of August 6, 2025, falls under the Defense Logistics Agency's Medical Supply Chain program and represents a task order issued against Arthrex's larger Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded Arthrex Inc. a delivery order valued at $6,254.34 for 10 million single-use oats sets on September 11, 2025, with an ultimate completion date of September 16, 2025. The contract employs fixed-price pricing with economic price adjustment and carries no set-aside designation. Arthrex, a global leader in minimally invasive orthopedic medical technologies headquartered in Naples, Florida, will perform the work at its Naples, FL...
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D625F0XWYDelivery Order
Arthrex Inc., a leading orthopedic medical device manufacturer headquartered in Naples, Florida, was awarded a delivery order valued at $1,095.12 on August 13, 2025, for 12mm single-use OATS (Osteochondral Autograft Transfer System) disposable kits. This fixed-price delivery order, with an economic price adjustment provision, is scheduled for completion by August 18, 2025, and will be performed at Arthrex's Naples facility. The award was issued under the Defense Logistics Agency's Medical Supply Chain, a defense agency function, with no set-aside designation applied. This delivery order represents a task order under Arthrex's larger Indefinite Delivery Contract with the Defense Logistics Agency (SPE2DE24D0020), valued at approximately $471 million and running through September 2029. The IDC enables Department of Veterans Affairs medical centers and military healthcare facilities nationwide to procure Arthrex's comprehensive portfolio of orthopedic surgical technologies and implants. OATS kits are specialized bone grafting systems used in orthopedic procedures to address cartilage and bone defects, particularly in joint reconstruction surgeries. As a Subchapter S Corporation without a small business designation, Arthrex has demonstrated significant competitive strength in the federal healthcare procurement market, having accumulated over $550,000 in delivery orders under this IDC since its inception.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/13/25 |